In February, IDPC held a meeting in the UK with some of its members to review its mission, vision and strategy for the coming three years, and to empower a group of individuals to speak on behalf of the Consortium at events and conferences.
As a response to rising levels of use, particularly in South East Asia, the CND has passed resolutions urging member states to employ national control systems to restrict the use of ketamine to medical and scientific purposes within their own jurisdictions, but INCB fails to account for the broader health implications of its proposal.
The meeting aimed to mend broken relationships, establish a platform for future engagement, and develop a clear action plan for the coming two years to address the concerns that had been raised.
The revised guidance provides countries with a more user-friendly framework of indicators and targets – including important new measures of the drug policy environment in which they operate.
In December 2012, individuals representing community, civil society, government and intergovernmental bodies met to engage in informal dialogue about drug policy issues in Southeast Asia and India.
In September 2012, I was invited to rapporteur for HIT’s second “Hot Topics” conference in the UK, which attracted 140 delegates from across the country.
In November 2012, the Uganda Harm Reduction Network (UHRN) sent a delegation of three staff to visit the progressive harm reduction services in Dar es Salaam, Tanzania. The study visit was coordinated and funded by the International Drug Policy Consortium (IDPC) and Harm Reduction International (HRI) as part of the on-going network development in Africa. Two IDPC staff also took part in the visit.
